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Honourable members, learned guests, 
members of the Indian Psychiatric Society and 
friends, it is a great privilege that I have been 
selected to deliver the prestigious Tilak 
Venkoba Rao Oration. I wish to thank the In-
dian Psychiatric Society for bestowing this 
award. I pay my respect to 'Tilak' worthy son of 
worthy parents Professors Venkoba Rao and 
Parvathi Devi, in whose memory this oration has 
been instituted for younger members of the 
society. 
I wish to thank my alma mater - King 
George's Medical College Lucknow and all my 
teachers who have guided me to become a 
psychiatrist. 
This recognition from the scientific com-
munity and encouragement from my seniors will 
spur me to even greater hard work in my re-
search and persuit for that truth which is the 
Goddess of all scientists. 
INTRODUCTION 
The importance of suicide needs no em-
phasis; it is by far the most frequent cause of 
death from mental disorders, and is among the 
ten leading causes of death the world over. 
Earlier research focused mainly on psychologi-
cal factors in the etiology of suicidal behaviour; 
biological factors were thought to be non-exis-
tent, or at least unimportant. The search for 
biological markers or etiology of suicidal be-
haviour was spurred partly by the inability of 
psychologically oriented studies to adequately 
explain and predict suicidal behaviour. 
OVERVIEW OF BIOLOGICAL 
MARKERS OF SUICIDAL BE-
HAVIOUR 
The search for a biological marker for 
suicide was initiated by the reports of Bunney et 
al. (1965,1969) who found high levels of urinary 
17-hydroxycorticosteroids in suicidal depres-
sives though Levy & Hansen (1969) failed to 
replicate this. As shown in Figure 1, the impor-
tant biological markers elucidated so far pertain 
to Neuroendocrine function and to 
Monoaminergic neurotransmission. 
Thoughactivation of the Hypotbalmic-
Pituitary-Adrenal axis (increasedcortisol 
levels.abnormal Dexamethasone Supression 
test) has been found to be more common in 
suicidal than in non-suicidal depressed patients 
(Traskman et al., 1980; Caroll et al., 1981; Banki 
et al., 1981, 1984; Coryell and Schlesser, 1981; 
Reus, 1982; Targum et al., 1983; Lopez-Ibor et 
al., 1985) results in nondepressed suicide at-
tempters have been conflicting. An abnormality 
of the Hypothalmic-Pituitary-Thyroid axis in 
the form of a blunted Thyroid Stimulating Hor-
mone response to Thyrotropin Releasing Hor-
mone has been related to an increased 
incidence of completed suicide (Linkowoski et 
al., 1984). 
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Studies of monoamines and monoamine 
metabolites in the brains of patients who com-
mited suicide were first published in the 1960's 
aiming to elucidate biological factors in depres-
sion which was believed to be the cause of 
suicide (this is partly true - it is the commonest 
disorder underlying suicide). In relation to the 
Dopaminergic system. Traskman et al. (1981), 
Montgomery and Montgomery (1982), and 
Agren (1983) showed that suicidal depressives 
had lower CSF homovanillic acid (HVA) the 
major dopamine metabolite, than nonsuicidal 
ones. There is reason to believe, however, that 
low CSF HVA as a predictor of suicide may be 
limited to depression (Traskman et al., 1981; 
Ninan et al., 1985) and, therefore, perhaps re-
lated to it rather than to suicidal behaviour as 
such. Further, it may be limited among depres-
sives prone to violent attempts (vide infra) only 
(Banki et al, 1984). Van Pragg et al. (1990), in 
their stimulating presentation of a hypothesis of 
the relation between monoamines and abnor-
mal behaviour, have offered evidence to sup-
port their view that low dopaminergic activity is 
related to motor retardation and inertia ir-
respective of the diagnosis. Whether low CSF 
HVA is a better predictor of suicide than low 
CSF 5-hydroxyindoleacetic acid (5-HIAA) or 
vice-versa is not clear (Banki et al., 1984; Roy et 
flZ.,1986). 
As regards the Noradrenergic system, 
only a few studies have investigated CSF levels 
of 3-methoxy-4-hydroxy phenylglycol (MHPG), 
the major noradrenaline metabolite, in relation 
to suicidal behaviour, and the findings have 
been conflicting. 
Initially, Serotonergic system markers 
were studied in relation to depressive be-
haviour, but later research also focused on 
suicidal behaviour as such and considerable, 
cosistcnt evidence has accumulated relating 
them to it, as discussed in this paper. 
WHY CSF 5-HIAA? 
Although various markers of serotoner-
gic activity in the brain are known and have been 
studied in relation to suicidal behaviour as well, 
the most commonly studied marker is CSF 5-
HIAA (it was the focus of our work, too) be-
cause for prediction of suicide, studies have to 
be antemortem and here the brain is not usually 
accessible directly; CSF is not very difficult to 
obtain for study and is a far better repre-
sentative of brain function than blood or urine. 
The extent to which marker in the latter two 
reflect serotonergic neurotransmission in the 
brain is not clear. 5-HIAA is by far the major 
metabolite of serotonin, and its levels in the CSF 
have been shown to correlate with sertonergic 
function in the brain. 
However, CSF 5-HIAA as a marker or 
predictor of suicide has certain disadvantages 
viz. hospitalization is required for lumber punc-
ture; a highly standard procedure has to be 
adopted as nuemerous factors affect its levels 
(vide infra); a drug-free period is required prior 
to drawing the sample and lumber punctures do 
not consent to it. 
The present paper, being concerned 
with the prediction of suicide, will emphasize on 
CSF 5-HIAA related finding, though briefly 
reviewing other markers and post-mortem 
studies. 
FACTORS TO BE CONSIDERED 
IN INTERPRETING THE STUDIES 
1. DIAGNOSIS 
A) The diagnostic category of suicidal sub-
jects is important because abnormalities in rela-
tion to monoamine activity have been found in 
nonsuicidal psychiatrically disordered patients, 
especially depressives, as well. Low CSF 5-
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numerous studies (Post et al., 1980- review of 15 
studies; Gibbon and Davis, 1985). A greater 
incidence of low CSF 5-HIAA is found in major 
depression than in other types (van Pragg and 
Plutchik, 1984); melancholic than in non-
melancholic depression; delusional than in non-
delusional depression and more severe 
melancholic depression (van Pragg et al., 1986) 
Thus, it is also important to know the 
subtype and severity of the depression. 
B) van Pragg et al. (1986) argued that the 
retrospective diagnosis of Nondepressed 
suicide attempter was unreliable because a 
depressive syndrome prior to the attempt is very 
common (Beskow, 1979; van Pragg, 1982a,b), 
and the rated severity of depression decreases 
substantially after the suicide attempt ( van 
Pragg and Plutchik, 1985) the hypothetical 
cathartic effect of attempted suicide. 
2. REPRESENTATIVENESS OF 
THE SAMPLE 
Most research in biological psychiatry is 
conducted at tertiary referral centres and it is 
usually not known how far the sample repre-
sents the usual patients. Treatment resistant 
patients and otherwise complicated cases who 
may be biologically deviant are probably over-
represented in such samples (Asberg et al., 
1986 a). 
3. CRITERION FOR SUICIDAL BE-
HAVIOUR 
Three indicators of suicidal behaviour 
have been used: 
1) suicidal attempt 
2) completed suicide 
Which of these is used makes all the 
differences. Most studies (including my own 
work) focused on suicidal attempters. How-
ever, there is an important difference between 
suicide attempters and completers. Only about 
2% of suicide attempters actually commit 
suicide in the first year after the attempt (Et-
tlinger, 1975). In most cases it can be deter-
mined that the subject did not definitely intend 
to die. 
Most rating scales view suicidal ideation 
and attempts as a continuum of increasing 
severity of suicidal tendency. Though this may 
be justified in the assessment of suicidal risk, 
biological markers of suicidal thoughts may be 
very different from those of actual attempts 
(Asberg et al., 1986 a). Notably, Asberg et al. 
(1976) found that CSF 5-HIAA was correlated 
with suidides attempts but not to suicidal idea-
tion or rated suicide risk and this has been found 
in my studies of depressed and schizophrenic 
suicide attempters as well, though others found 
correlation with both, as discussed below. 
4. RECENT OR LIFETIME 
SUICIDE ATTEMPTS 
It is important to distinguish a correla-
tion with recent suicidal attempts which may 
reveal a state marker, from correlation with 
lifetime suicidal attempts which may yield a trait 
marker. 
5. SERIOUSNESS OF THE 
SUICIDAL ACT 
Suicidal acts have frequently been 
divided into violent and nonviolent depending 
on the method used (Paykel and Rassaby, 
1978). Drug overdose and superficial wrist cut-
ting are nonviolent suicide, while all other 
methods are trait violent. 
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van Pragg et al. (1986) has convincingly 
argued that the strength of the intent to die is 
also determined by choice of a situation in 
which the chances of being rescued are lesser. 
These two have been combined in the Risk-res-
cue Scale of Weisman (1972) and van Pragg et 
al. (1986) using this scale found no significant 
difference in scores on it between subjects 
simply classified as violent and nonviolent 
suicides. 
6. FACTORS AFFECTING CSF 5-
HIAA CONCENTRATION 
These factors, which have to be control-
led for any meaningful study include age (As-
berg & Bertilsson, 1979) - higher with 
increasing age; sex (Asberg ef al., 1973; Asberg 
and Bertilsson, 1979; Royet al., 1990) - lower in 
males; body height (Wode-Helgodt and Sed-
vall, 1978; Asberg and Bertilsson, 1979; Curzon 
et al., 1980; Banki & Molnar, 1981) - lower in 
taller subjecs; time of the year (Asberg et al., 
1981; Losonczy et al., 1984) - higher in winters; 
time of the day (Nicoletti et al., 1981; Garrick et 
al., 1983) - higher at night; physical activity 
(Fotherby et al., 1963; Post et al., 1973); Various 
physical diseases (Anderson & Roos, 1969; 
Johansson & Roos, 1967; Anderson etal., 1981; 
Hallert et al., 1982); antipsychotic drugs 
(Bjerenstedt et al., 1977; Gomes et al., 1980; 
Gattaz et al., 1982); antidepressent drugs 
(Bowers, 1972; Asberg et al., 1973; Post & 
Goodwin, 1974; Muscettola et al., 1978; 
Traskman et al., 1979; Bertilsson et al, 1980) -
Lower levels; dexametfaasone (Banki et al., 
1981) - Higher levels; diet (Curzon et al., 1972; 
Asberg et al., 1986 b); position of the patient for 
lumbar puncture (Sedvall & Oxentierna, 1986); 
intervertebral space used (Nodin et al., 1982) -
lower in lower space; amount of CSF drawn 
I (Asberg et al., 1986b); analytical method used 
(Sjoquist & Johansson, 1978) - Mass fragment 
tography is superior to spectrofluorometry (As-
berg et al., 1986b) and CSF pressure and flow 
(Post *<*/., 1973 a). 
Diurnal and circannual variation of 
serotonergic activity in the brain has been 
directly demonstrated (Carlsson et al.. 1980) 
Postmortem brain studies of CSF 
serotonergic activity are affected by similar fac-
tors including time and mode of death, time to 
discovery of the body and autopsy (decay of 
monoamines and their metabolites), and drug 
treatment. 
7. BASAL CSF 5-HIAA AFTER 
PROBENECTD/SULFINPYRAZO -
NE 
Administration of probenecid or sulfin-
pyrazone blocks the exit of 5-HIAA from the 
CSF and the accumulation of 5- HIAA in the 
CSF indicates serotonin degradation in the 
CNS. Though most studies have measured only 
basal 5-HIAA, van Pragg used probenecid in 
several studies (e.g., van Pragg, 1977, 1982a, 
1982b, 1983) as did Post et al. (1980), and we 
have used sulfinpyrazone in one study. 
CSF 5-HIAA AND SUICIDAL BE-
HAVIOUR 
Early studies of CSF 5-HIAA in depres-
sion found it to be lowered but did not note any 
psychopathological difference between 
patients with or without decreased CSF 5-
HIAA except higher anxiety ratings in those 
with low CSF 5-HIAA (van Pragg, 1986a). The 
first finding of correlation between suicide and 
a biological marker in the CSF occured to some 
extent by chance. Asberg et al. (1976) in 
Sweden, Who studied CSF 5-HIAA in depres-
sives and found lower values in some patients, 
searched for clinical differences in the two 
groupsof patients, and unexpectedly found an 
increased incidence (40% in index episode in 
low CSF 5-HIAA group vs. 15% in normal CSF 
5-HIAA group) of suicide attempts especially 178  J.K.TRIVEDI 
Table 1: Studies of CSF 5-HIAA as marker of Suicidal Behavioor 
WORKERS 
Asbergetal. 
(1976) (Sweden) 
Vestegaard et al. 
(1978) 
Brawn et al. 
(1979) (U.S.A.) 
Agren(1980) 
Traskman et al. 
(1981) (Sweden) 
Leckman et al. 
(1981) 
Oreland et al. 
(1981) (Sweden) 
SAMPLE 
Unipolar endogenous & 
feactive depresives 
(IS attempters S3 non 
attempters) 
Unipolar & bipolar 
depressives 
Primary DSM-III 
personality disorder 
(males in military) 
(llattempters, 11 non-
attempters) 
33 unipolar and bipolar 
depressives 
30recentattempters (8 
minor depressidn on New 
Castle Inventory, 22 other 
psychiatric disorders 
excluding schizophrenics 
substance abuse & organic 
brain syndrome) 45 
healthy controls 
132 psychiatric patients 
# 20 depressives, 
# IS recent suicide 
attempters (minor 
depression, anxiety states, 
personality disorder) 
# 11 recovered 
depressives 
# 42 healthy controls 
ASSESSMENT 
OF 
SUICIDALITY 
Attempted suicide 
in index episode 
Suicide atttempt 
Lifetime suicide 
attempts 
SADS suicidality 
scale 
Recent suicide 
attempts 
Nurse's ratings of 
suicidal tendencies 
Recent suicide 
attempters 
FINDINGS OF 
CSF 5-HIAA 
Lower in atempters, 
significantly only in violent 
attempters(Sex, height, etc 
not considered) 
No difference (proportion of 
violent & non-violent 
attempters not reported) 
Lower in attempters 
Trivariate relation including 
aggression. 
Negative correlation 
(Proportion of violent and 
non violent attempters not 
reported) 
Lower in attempters 
especially violent (Ruled out 
sex factor for first time) 
Negative correlation 
(Proportion of violent & non 
violent attempters not 
reported) 
Lower in attempters BIOLOGICAL MARKERS OF SUICIDAL BEHAVIOUR  179 
Brown et al. 
(1982a) (U.S.A.) 
van Pragg (1982a) 
(Holland) 
van Pragg (1983) 
Palaniappan et 
al.(1983) (India) 
Agren (1983) 
Roy-Byrne et al. 
(1983) (U.S.A.) 
Linnoila et al. 
(1983) 
Banki and Arato 
(1983) (Hungary) 
Banki et al.(1984) 
(Hungary) 
12 males (in military) with 
DSM-III Borderline 
personality disorder; 5 
attempters, 7 
nonattcmpters) 
203 depresives (54 
attempters, 149 
nonattempters) 
# lOnondepressed 
schizophrenic attempters 
#10nonsuicidalnondepres 
sed schizophrenics 
# 10 controls 
40 depressive inpatients 
110 unipolar & bipolar 
depressives 
32 bipolar depressives, 13 
unipolar depresives 
(Mainly treatment 
resistant patients at a 
tertiary center) 
20 violent offenders 
57 female inpatients 2 DSM-
III diagnoses (14 major 
depression-4 bipolar, 7 
unipolar, 3 first episodes; 
14schizoplirenics;4schizop 
hreniform disorder; 13 
alcohol 
dependence, 12others;10no 
violentatiempters,4violenta 
ttempters,4nonattempters) 
141 females including 45 
previously reported (36 
major depression-
unipolar or bipolar, 46 
schizophrenic/schizophr 
eniform , 35 alcoholics, 24 
adjustment disorders; 18 
# Lifetime suicide 
attempts 
# MMPI 
Recent suicide 
attempts 
# Recent suicide 
attempt due to 
command 
hallucinations 
# Risk-rescue scale 
Suicide item of 
HRSD 
SADS suicidality 
scales 
Lifetime suicide 
attempts 
Suicide attempt 
Recent suicide 
attempt 
Recent suicide 
attempt 
Lower in attempters 
Trivariant relationship 
included aggression 
Lower in attempters, equally 
in violent & nonviolent 
attempters 
Normal range but lower in 
attempters especially those 
scoring higher on risk-rescue 
scale 
Negative correlation 
Negative correaltion in 
unipolar depressives 
NoDifferenccNonsignifican 
tly lower in unipolar 
depressive attempters. 
Lower in attempters with 
explosive or antosocial 
personality 
Lower in violent attemters 
only 
Lower in violent attempters 
in all diagnoses, lower in 
nonviolent attempters only in 
alcohol dependence 180  J. K. TRIVEDI 
Ninan et al. 
(1984) (U.S.A.) 
Perez de los 
Cobos et al. 
(1984) (Spain) 
Roy et al.(1985) 
(U.SA.) 
Lopez-Ibor et al. 
(1985) (Spain) 
Lidberg et al. 
(1985) (Sweden) 
Berretini et al. 
(1986) (U.SA.) 
Pickar etal. 
(1986) (U.S.A.) 
Roy et al. (1990) 
(USA) 
violent attempters; 34 
nonviolent attempters) 
DSM-III & RDC 
schizophrenics, 8 suicidal 
(committed suicide or 
would have committed) 8 
nonsuicidal (no suicidal 
thought or act) 
21 depressives 
54 DSM-III 
schizophrenics (27 
attempters, 27 non 
attempters) 
21 DSM-III MAjor 
depression with 
melancholia 
# 20 suicide attempters 
(11 depressives, others 
anxiety states and/or 
personality disorders) 
# 39 heakthy controls 
# 15 euthymic bipolar 
disorders (6 attempters, 9 
nonattempters; 3 violent, 3 
nonviolent) 
# 30 healthy controls 
28 DSM-III 
schizophrenics (13 
attempters, 15 
nonattempters) 
#DSM III alcohol 
dependence (20 
attempters, 108 
nonattempters) 
#30 healthy controls 
Lifetime suicide 
attempts (through 
clinical and 
research records) 
# Suicide attempt 
# Suicide item for 
HRSD 
# AMDP system 
items for suicidality 
Lifetime suicide 
attempts 
#HRSD 
# AMDP system 
Suicide attempt in 
index episode 
Lifetime suicide 
attempt 
Lifetime suicide 
attempts (through 
records) 
Lifetime suicide 
attempt on 
SADS- L 
Lower in suicidal (Proportion 
of violent & nonviolent 
attempts not reported) 
Negative ccorrelation with 
attempta & suicide items of 
the scales. Equally in violent 
& nonviolent attempts 
No difference 
Negative correlation with 
aggressive & suicidal 
behaviour. 
Lower in attempters 
especially violent attempters 
No difference 
No difference (Excluded 
persistently suicidal patients) 
No difference BIOLOGICAL MARKERS OF SUICIDAL BEHAVIOUR  181 
by violent methods in the low CSF 5-HIAA 
group. 
The studies of CSF 5-HIAA in relation 
to suicidal behaviour in depression and other 
psychiatric disorders are summarized in table 1. 
All the studies which considered a recent 
suicidal attempt found a low CSF 5-HIAA. Of 
studies which used lifetime history of suicide 
attempts as a variable all but two found low CSF 
5-HIAA correlated with it. Even the negative 
study of Roy-Byrnes al. (1983) found low CSF 
5-HIAA in suicide attempters when unipolar 
cases were considered separately. The higher 
proportion of bipolar patients in their sample 
then explains the negative overall result. Roy et 
al. (1985), the same group which had reported 
a negative correlation in schizophrenia between 
CSF 5-HIAA and lifetime suicidal ideas or at-
tempts (Ninan et al., 1984) failed to reproduce 
their findings. Roy et al. (1990) failed to find 
lower CSF 5-HIAA in patients of DSM-IIl al-
cohol dependence with history of lifetime 
suicide attempts. Possible reasons for the nega-
tive findings include remoteness of the attempts 
(the correlation with low CSF 5-HIAA is 
strongest for recent attempts; van Pragg, 1991), 
small proportion of violent attempts, failure to 
exclude depression not amounting to DSM-III 
diagnosis in the non-attempters, and the known 
relationship between alcohol dependence and 
depressive disorders. Low CSF 5- HIAA has 
been found in abstinent alcoholics without 
suicide attempts (Ballenger et al., 1979; Banki, 
1981). 
The postmortem CSF study in com-
pleted suicides of Kauert et al. (1981) found 
increased serotonergic activity. However, the 
time of death of suicides and controls was not 
similar or compensated for, which may explain 
this anomalous finding. Studies using rating 
scales for suicidality also found a negative cor-
relation with CSF 5-HIAA. 
The studies do not agree on: 1) Whether 
CSF 5-HIAA is negatively correlated with 
ratings of suicidality; 2) Whether CSF 5-HIAA 
is negatively correlated with suicidal ideation 
with suicidal acts and 3) Whether CSF 5-HIAA 
is lower in violent than in nonviolent suicides. 
The relationship with CSF 5-HIAA to 
suicidality has been demonstrated in depres-
sion, schizophrenia, personality disorders, al-
coholism, adjustment disorders, etc. and in 
relation to current ratings of suicidality, recent 
suicide attempts, and lifetime suicide attempts. 
Thus, the evidence for this correlation is quite 
robust. 
I would now like to briefly present my 
three studies on serotonergic markers in rela-
tion to suicidal behaviour. In all three CSF 5-
HIAA and platelet/plasma/serum serotonin 
were chosen as markers of serotonergic 
neurotransmission but results with the latter 
being inconsistent are not being discussed here. 
The factors affecting CSF5-HLAA leve^' 
were controlled: age, sex and body height >J?y 
matching the study groups and the control 
group; physical diseases which may affect CSF 
5-HIAA were an exclusion criterion; effect of 
medication by a drug-free period of one week 
in the first two studies and of two weeks in the 
third, and in the study on schizophrenics, by 
excluding those on depot antipsychotics; 
dietary factors by prohibiting certain foodstuffs 
and by overnight testing before lumber punc-
ture; effect of physical activity by bed rest and 
ensured sleep prior to the lumber puncture; 
time of the day, position of the patient for lum-
ber puncture, intervertebral space used, 
amount of CSF drawn, handling and storage of 
CSF, and analytical method used were the same 
in all subjects. 
In all the three studies, psychiatrically 
normal controls were drawn from patients un-
dergoing spinal anesthesia for surgery who had 
no past, present, or family history of mental 
disorder. 182  J. K. TRIVEDI 
The first study, on schizophrenics, used 
the sulfinpyrazone technique of accumulation 
of 5-HIAA in the CSF while the other two 
measured basal CSF 5-HIAA. 
The first two studies, on RDC 
schizophrenics in 1986 and on RDC primary 
depressives in 1987, were similar, and I will 
discuss them together. The schizophrenics were 
evaluated on the Modified Brief Psychiatric 
Rating Scale (MBPRS; Overall and Gorham, 
1962) and the depressives on the Hamilton 
Rating Scale for Depression (Hamilton, 1960). 
In addition, the Suicidal Intent Qustionnaire 
(SIQ) developed and evaluated at our depart-
ment by Gupta et al. (1983), of which team I was 
also a part, was used in both studies. The ques-
tionnaire divides patients into definite com-
municators (score < =5), partial 
communicators (score 2-4), and noncom-
municators (score < =1). Partial com-
municators were excluded from the study. 
In the study of schizophrenics, 20 
definite communicators, 20 noncom-
municators, and 10 normal controls were 
studied. The study on depressives including 15 
subjects of each category. Six of the 20 definite 
communicator schizophrenics had attempted 
suicide in the index episode (5 violently and 1 
nonviolently) while 3 of the 15 definite com-
municator depressives had done so (2 violently 
and 1 nonviolently). 
The findings supported the following 
main conclusions: 
* The severity of the disorder did not corre-
late with CSF 5-HIAA levels as shown by ab-
sence of a significant correlation with MBPRS 
or HRSD scores. 
* However, CSF 5-HIAA did show a cor-
relation with components of these scales. In 
definite schizophrenics it was significantly 
(p<0.05) negatively correlated with the 
Anxiety-Depression derived variable of the 
MBPRS, i.e. those with lower CSF 5-HIAA had 
higher score on the Anxiety-Depression vari-
able. CSF 5-HIAA was significantly negatively 
(p < 0.01) correlated wirh the suicide item of the 
HRSD in the depressives. 
* We concluded indirectly that low CSF 
5-HIAA was significantly correlated only with 
suicide attempts and not with suicidal ideation 
alone because : in both schizophrenics and 
depressives, CSF 5-HIAA of suicide attemptors 
among the definite communicators was sig-
nificantly less than that of normal controls 
(p<0.05 for schizophrenics arid p<0.01 for 
depressives; Figure 2 and 3); in both studies, 
both communicators and noncommunicators 
and nonattempters among the definite com-
municators did not have significantly different 
CSF 5-HIAA than normal controls (Figure 2 
and 3); CSF 5-HIAA was not significaantly cor-
related to SIQ scores in either diagnostic 
cateegory, when CSF 5-HIAA of definite com-
municators (with or without a suicidal attempt) 
was compared with that of non-communicators 
and normal controls. 
In the schizophrenics, there was a maxi-
mum trend for CSF 5-HIAA to be lower in 
definite communicators than in normal con-
trols, though it did not reach statistical sig-
nificance (Figure 4). In the depressives, CSF 
5-HIAA of definite communicators was less 
than that of non-communicators (p<0.01) and 
normal controls (P< 0.001), while that of non-
communicators was not significantly different 
from that of normal controls (Figure 5). 
In our third study, done in 1988, we 
moved from questionnaire rating of suicidality 
that covered both suicidal ideation and at-
tempts with only a few patients having history of 
a suicide attempt, to a direct study of suicide 
attemptors. Three groups were evaluated: 
1) 23 nonpsychotic nondepressed subjects 
with a history of recent nonviolent suicide at-BIOLOGICAL MARKERS OF SUICIDAL BEHAVIOUR  183 
tempt. One patient had also made an attempt in 
the past. 
2) 14 RDC primary depressives (two-third 
bipolar and one-third unipolar). Eight had 
recent attempts (two had past attempts as well 
) while six had only past attempts (defined as 
more than 6 months prior to evaluation). Of the 
total of 18 suicide attempts in this group, 10 
were violent and 8 were nonviolent. 
3) 10 normal controls 
As in the previous studies, severity of the 
disorder (HRSD scores) did not correlate sig-
nificantlywith the CSF 5- HIAA. CSF 5-HIAA 
in the different groups is shown in Figure 6, 7 
and 8. These finding suggest that low CSF 5-
HIAA is correlated : 1) To suicide attempts 
irrespective of the presence or absence of 
depression. 2) More strongly to violent attempts 
to CSF 5-HIAA than to nonviolent attempts, 
though significantly to both. 
The correlation of suicide attempts to 
CSF 5-HIAA may apply more so to unipolar 
depressives as they had significantly (p < 0.001) 
lower CSF 5-HIAA than bipolar depressives 
(Figure 9) which was also found by Roy-Byrne 
et al. (1983) who analysed unipolar and bipolar 
patients separately. CSF 5-HIAA, though 
reported to be low even in those with only past 
suicide attempts, may be lower in those with 
recent attempts as among the depressives we 
found it to be lower in those with recent at-
tempts than in those with past attempts only, 
though this difference did not reach statistical 
significance (Figure 10). 
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PERSISTENCE OF A LOW CSF 
5-HIAA 
The assessment is difficult and rarely 
done because: 
1) There is a variation in CSF 5-HIAA con-
centrations with the time of the year (vide 
supra). 2) Only few patients are available as 
most are on drugs and/or do not give their 
concent for a repeat lumber puncture (once 
recovered). 3) The few patients available may 
be nonrepresentative. 
Coopen etal. (1972) found CSF 5-HIAA 
levels to be stable in 8 subjects followed for 3-59 
weeks, van Pragg (1977) reported that in 50 
subjects followed for more than six months, CSF 
5-HIAA levels were stable in those with normal 
levels and in more than 50% off those with low 
levels, the rest having normalized. Traskman-
Bendz et al. (1984) who studied 11 subject over 
2-7 years found the levels stable in those with 
normal levels while they rose in those with low 
levels, though not to normal. 
Thus, at present low CSF 5-HIAA ap-
pears to be stable over liited periods at least in 
most patients and if it does increase, it does not 
return to normal in those periods. It also tends 
to be similar in each episode of depression. 
LOW CSF 5-HIAA AND SUB-
SEQUENT COMPLETED SUICIDE 
Asbergef a/. (1986b) followed 76 suicide 
attemptors for one year and reported that 21% 
of low CSF 5-HIAA patients committed suicide 
while 2% of those with normal or high CSF 
5-HIAA did so. As mentioned already, CSF 
5-HIAA level tends to be similar in subsequent 
episodes in many patients. Asberg et al. (1986b) 
made repeated estimations in two patients who 
subsequently committed suicide and in both the 
CSF 5-HIAA was substantially reduced in the 
second estimation compared to the first. They 
suggested that some patients of depression may 
have low as well as stable CSF 5-HIAA. Perhaps 
a low and decreasing CSF 5-HIAA may be the 
most ominous sign of all. 
Roy et al. (1986 b) also found an in-
creased incidence of completed suicide in 
suicide attempters with low CSF 5- HI AA. They 
studied 27 cases of major depression (22 
unipolar and 5 bipolar) of which 19 had at-
tempted suicide, 3 by violent and 16 by non-
violent methods of which 4 had recently 
attempted. The difference between attempters 
and nonattempters was maximum for 5-HIAA. 
In one year follow up 4 completed suicide which 
included 3 of the 7 with low CSF H VA and 2 of 
the 8 with low CSF 5-HIAA. Lopez-Ibor et al. 
(1985) reported that the two patients with the 
lowest CSF 5- HIAA levels in their sample had 
to be later withdrawn from the study due to risk 
of suicide; both committed suicide within one 
year of termination of the study of a subsequent 
relapse. Traskman et al. (1981) who followed up 
119 patients for about a decade reported that all 
the 7 who had committed suicide had CSF 5-
HIAA below than median. 
SUICIDAL BEHAVIOUR AND 
OTHER MARKERS OF SEROTON-
ERGIC NEUROTRANSMISSION 
Table 2 Markers Of Serotonergic 
Neurotransmission 
BRAIN 1. Serotonin 
2.5-HIAA 
3. [3H] (i.e., tritiated) imipramine 
binding 
4. [3H] (i.e., tritiated) spiroperidol 
binding 
5. MAO activity 
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2. Ratio of plasma tryptophan or 
other neutral aminoacids 
(important determinant of 
tryptophan transport into CNS; 
Fernstorm & Wurtman, 1972) 
3. Platelet [3H] imipramine 
binding 
4. Platelet serotonin intake 
5. Free tryptophan (rate limiting 
factor in the synthesis of 
serotonin). 
As Table 2 shows, there are several 
markers of serotonergic activity - its precursor, 
the parent compound, its binding sites, the en-
zyme degrading it, and its metabolite, which are 
related to the brain itself or to the platelet as a 
model for brain serotonergic activity. As they 
have little value in themselves as predictors of 
suicidal behaviour, only some of them will be 
discussed very briefly. 
BRAIN (Postmortem studies) 
The findings are generally consistent 
with reduced serotonergic activity in the brain 
of suicide victims. 
1. Serotonin 
2.5-HIAA 
Some but not all studies have found 
lower concentrations of serotonin or 5-HIAA in 
brains of completed suicides, either in the hind 
brain or in the hypothalamus ( Asbcrg et al., 
1986b-review of 7 studies). Mann et al. (1989) 
who reviewed 12 studies of serotonin and 5 
studies of 5-HIAA levcss in the brains of suicide 
victims observed that some, but not all, studies 
reported modestly lower levels of 5-HIAA 
and/or 5-HT in the brain-stem but not the cor-
tex. Lloyd et al. (1974) estimated serotonin and 
5-HIAA in neurons are placed rather than 
larger segments of brain matter and found 
lower serotonin concentrations in two of the 
nuclei. The disparate results of other studies 
may be due to a failure to study discrete enough 
segments. 
3. [3H] Imipramine binding - It is probably 
related to and the best marker for the presynap-
tic serotonin uptake site. Contradictory results 
(higher, normal or lower binding) have been 
reported in suicide victims since the initial 
report of fewer binding sites by Stanley et al. 
(1982) (Mann et al., 1989-review of 8 studies). 
Possible methodological reasons for the con-
tradictory findings have been discussed by 
Mann et al. (1989). Whether or not 5-HTi 
receptors or their subpopulations are increased 
in the brains of suicide victims is not clear 
though Meltzer (1988) has reported an increase 
in 5-HTIA receptors. 
4. [3H] Spiroperidol binding - It is a marker 
of post synaptic serotonin-2 binding sites. Owen 
et al. (1983) and Staley and Mann (1983) 
reported increased binding, consistent with 
decreased serotonergic neurotransmission 
suggested by the CSF studies. The majority, 
Though not all, studies have found an increased 
number of 5-HT2 receptors in the pre-frontal 
cortex of suicde victims which is consistent with 
decreased serotonergic activity (Mann et al., 
1989). 
5. MAO activity - While Gottfries et al. 
(1975) found lower MAO activity in alcoholic 
suicide victims than in controls, Grote et al. 
(1974) and Mann and Stanley (1984) found it to 
be similar to controls. 
BLOOD 
1. Platelet activity - Buchsbaum et al. (1976) 
reported increased incidence of suicide at-
tempts in subjects with very low platelet MAO BIOLOGICAL MARKERS OF SUICIDAL BEHAVIOUR  191 
activity and their relatives. Buchsbaum et al. 
(1977) also found a correlation between low 
activity and suicidal behaviour, but only in those 
who were also augementers on evoked respnse 
tests. Gootfries et al. (1980) found it lower in 
depressives with violent suicide attempts than, 
in those with nonviolent or no attempts. 
2. Plasma tryptophan/neutral amino acids 
ratio - Branchey et al. (1984) found the ration to 
be lower in alcoholics especially those with a 
history of suicidal and aggressive/impulsive be-
haviour. 
WHAT DOES LOW CSF 5-HIAA 
REALLY REPRESENT? 
This involves several questions : 
1. Does CSF 5-HIAA reflect serotonergicc 
I activity in the brain 
Bulat and Zivkovic (1971) suggested that 
CSF 5-HIAA may reflect serotonin turnover in 
the spinal cord transaction or spinal fluid block-
age in man does not affect lumber CSF 5-HIAA 
levels. However, Stanley etal. (1985) in rats have 
shown a strong correlation between CSF and 
5-HIAA. Weir et al. (1973) using radioactively 
labelled 5-HIAA in cats found that 70% of the 
lumber CSF 5-HIAA was derived from the 
brain. Banki and Molner (1981) showed that 
5-HIAA in lumber CSF correlated well with 
cisternal CSF. 
2. Does low CSF 5-HIAA denote low 
serotonergic activity? 
The findings in relation to other 
serotonergic markers suggest that this is so, but 
low CSF 5-HIAA could also be secondary to a 
hyperactive serotonergic system due to hyper-
sensitive postsynoptic receptors (Aprison et al., 
1978) and the issue is unclear (van Pragg et al., 
3. Is CSF 5-HIAA a trait marker or a state 
marker? 
Early studies focused only on the 
relationship between CSF 5-HIAA and recent 
suicide attempts but later a correlation with 
lifetime suicide attempts has been 
demonstrated by various studies. 
Low CSF 5-HIAA seems to be familial 
to an extent as evidenced by greater incidence 
of depression in relatives of subjects with low 
CSF 5-HIAA (van Pragg and De Hann, 1977) 
and low CSF 5-HIAA in relatives of patients 
with depression (Sedvall et al., 1980). 
Low CSF 5-HIAA has been correlated 
with certain personality traits. Brown et al, 
(1982) found a correlation between CSF 5-
HIAA and the Psychopathic Deviate Scale of 
the MMPI and noted that subjects with low CSF 
5-HIAA had previously shown disturbed be-
haviour in their childhood. Asberg et al. (1986a) 
noted a correlation with impulsivity on per-
sonality questionnaires, and a week but consis-
tent correlation with Eysenck's Psychoticism 
Scale. Schalling et al. (1984) reported that CSF 
5-HIAA levels correlates negatively with scores 
on the impulsiveness scale of the Karolinska 
scales of Personality. Rydin et al. (1982) 
reported a correlation with high hostility on 
Rorschach protocols. Intrestingly, in animals, 
drugs or lesions causing serotonin depletion 
may produce aggressive or impulsive (disin-
hibited) behaviour (Soubrie, 1986). 
These findings seem to suggest that low 
CSF 5-HIAA may be a trait marker. On the 
other hand, the possibility that a decreasing 
CSF 5-HIAA may represent the highest risk for 
suicide, the stronger correlation with recent 
suicide attempts than lifetime attempts, and the 
change in CSF 5-HIAA levels with time (though 
perhaps not to normal) indicate a" state charac-
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In my opinion it is not essential to view 
low CSF 5-HIAA as either a state marker or a 
trait marker - it may be both. Like van Pragg et 
al. (1990), I view CSF 5-HIAA as representing 
not any specific diagnostic categories or even a 
personality variable, but as a functional 
psychobiological defect. The biological corre-
late of this defect (CSF 5-HIAA) could be 
found both as a trait and a state marker. 
4. What is the functional defect of which low 
CSF 5-HIAA is a correlate? 
Psychoanalytic authors have stressed 
that both depression and suicide are related to 
aggression directed towards the self (Freud, 
1953). Menninger (1933) conceptualized the 
"wish to kill" as an element of the suicidal act. 
There is also considerable evidence (Brown et 
al., 1979, 1982; Valzeli, 1981; Linnoila et al., 
1983; Lidberg et al., 1984, 1985; Brown and 
Goodwin, 1986) linking low CSF 5-HIAA to 
outwardly directed aggression, especially, like 
suicide attempts, of an impulsive and more 
violent type. 
Thus, low CSF 5-HIAA may represent 
the functional defect of a disordered (especially 
impulsive and violent) aggression and autoag-
gression, both as a personality trait and as a 
state, and thus link depression, suicide, and 
externally directed aggression where it is found. 
Asberg et al. (1986a) noted that the impulsive 
nature of suicidal or aggressive acts which have 
been correlated with low CSF 5-HIAA may 
explain why it appears to be related to suicidal 
acts but not to suicidal ideation (though this 
latter is controversial). It is interesting to note 
that it is suspected that correlation of low CSF 
5HIAA and suicide is limited to unipolar 
depression, where the autoaggression 
hypothesis of depression is more likely to be 
valid than in bipolar disorder. However, Mann 
et al. (1989) have offered an alternative 
hypothesis that a decreased CSF 5-HIAA level 
is already associated with bipolar disorder, and 
any further decrease which may be associated 
with suicidal behaviour is less easily 
demonstrated. 
5. Is low CSF 5-HIAA genetic Or environ-
mental in origin? 
While the familial nature of the marker 
and data from twins (Sedvall et al. 1980 a,b, 
1984: higher concordance for CSF 5-HIAA in 
monozygotic than dizygotic twins) may support 
a genetic basis, findings in animals suggest that 
it may resuit from learned helplessness situa-
tions (Anisman et al., 1980) or prolonged social 
isolation (Valzelli, 1981). Psychological proces-
ses do not occur in a biological vacuum and the 
marker may well be acquired. 
6. How does low serotonin turnover interact 
with other factors in depression and suicide? 
Asberg et al. (1986b) hypothesized that 
the marker may represent a vulnerability to 
depression, suicide, and external aggression. It 
may manifest in a suicide attempt only when 
significant adverse events occur or when per-
ception of the situation is distorted by depres-
sion (Figure 11). Previous adverse events (e.g., 
early parental loss) may facilitate a more nega-
tive interpretation of the adverse events while 
factors like social support may contribute to 
ameliorating the effects of adverse events and 
depression. Thus, the authors note, we may be 
moving towards a psychobiology of suicide. 
Mann et al. (1989) have hypothesized 
that neurotransmitter systems other than 
serotonergic probably determine whether the 
aggression is directed inwards (suicide) or out-
wards. 
Carrot et al. (1981) opined that the 
Dexamethasone Suppression Test identifies a 
group of suicidal subjects different from that 
identified by low CSF 5-HIAA. This needs fur-
ther study as Traskamn et al. (1980) found high 
levels of Cortisol in the same depressed patients 
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TREATMENT IMPLICATIONS 
The correlation between low CSF 5-
HIAA and suicidal behaviour leads logically to 
the implication that drugs that enhance 
serotonergic activity should be evaluated as a 
specific treatment for it. 
Montgomery and Montgomery (1982) 
found that zimelidine , a selective serotonin 
reuptake inhibitor decreases suicidal ideas at 
the beginning of treatment. However, recent 
case reports associated treatment with 
fluoxetine with increase in suicidal ideation. 
Lopez-Ibof et al. (1989) found (nonsignificant) 
trends for patients with suicide attempts, 
greater self-aggressivity, and lower CSF 5-
HIAA levels to improve with treatment with 
5-hydroxytrytophan (a serotonin precursor). 
Morand et al. (1983) and Volavka et al. 
(1990) found trytophan to diminish aggressive 
behaviours in chronic schizophrenics. It has 
been suggested that drugs like carbamazepine, 
lithium and propranolol, which are effective in 
some cases of aggression, have important inter-
actions with serotonergic systems and should be 
evaluated in impulsive suicidal behaviour 
(Editorial, Lancet, 1987). 
Mann et al. (1989) have suggested that 
antidepressants may be effective in non-depres-
sive suicidal behaviours as well due to effects on 
the 5-HT2 and B receptors opposite to those 
found in the brains of suicide victims. 
CONCLUSIONS 
Markers of central serotonergic ac-
tivity, especially CSF 5-HIAA, may be one of 
the strongest predictors of suicidal behaviour. 
Sidney-Jones et al. (1990) found that while 
elderly suicide attempters had significantly 
lower CSF 5-HIAA levels than non-attempters, 
the Buss-Durkee Hostility Inventory (measure 
of aggression and impulsivity), the Brief 
Psychiatric Rating Scale, the Hamilton Depres-
sive Rating Scale and the Recent Life Changes 
Questionnaire failed to distinguish the two 
groups. However, the predictive ability of these 
markers needs to be evaluated by prospective 
studies. The author is at pains to emphasize that 
this review focussing on one important biologi-
cal variable should not be viewed as an over-
simplified , reductionist etiology of suicide. 
Psychological processes not only interact with 
biological factors but have biological correlates 
and results as well: the brain is the seat of the 
mind. It cannot be assumed (as in much of 
biological psychiatry) that these markers are the 
biological cause rather than the biological sub-
strate of the psychological processes underlying 
suicidal behaviour: psychological processes do 
not occur in a biological vacuum. For a unified 
psychobiological theory of suicide it is sug-
gested that relevant psychological and biologi-
cal variables be studied in the same group of 
patients to determine their interrelationships, 
eventually in prospective studies which would 
also evaluate their relative predictive ability. 
Some of the various drugs which interact with 
serotonergic systems may emerge as a treat-
ment for suicidal behaviour as such in a defined 
subgroup of patients. 
ACKNOWLEDGMENT 
I wish to thank Dr. Rajneesh Mago for 
'all' his help. 
REFERENCES 
Agren, H. (1983). Life at risk: Markers of suicidality in 
depression Psychiat Dev, 1,87-104. 
Andersson, H.; Root, B.E. (1966). Increased level of 5-
hydroxyindoleacetic acid in cerebrospinal fluid from infan-
tile hydrocephalus. Experientia, 22,539-541. 
Anderson, O.; Johansson, B.B.; Svennerhotm, L. (1981). 
Monoamine metabolites in successive samples of spinal 
fluid- a comparison between healthy volunteers and 194  J.K.TRIVEDI 
patients with multiple sclerosis. Acta Neurol Scand., 63, 
247-254. 
Anisman, H.; Pizzino, A.; Skalr, S. (1980). Coping with 
stress, norepinephrine depletion, and ezcape performance. 
Brain Res, 191,583-588. 
Aprlson, M.D.; Takahashl, R.; Tachiki, K- (1978). Hyper-
sensitive serotonergic receptors involved in clinical depres-
sion: A theory. In : Haber, B.; Aprison, M.H.; (Eds.). 
Neuropharmacology and Behaviour. New York, Plenum 
Press. 
Asberg, M.; Bertllsson, L. (1979). Serotonin in depressive 
illness- studies of CSF 5-HIAA. In : Saletu, B. (Ed.). 
Neuropsychopharmacology. New York, Pergamon Press, 
pp 105-115. 
Asberg, M.; Bcrtiisson, L.; Rydin, E.; Schalling, D.; 
Thoren, P.; Traskman-Bendz, L. (1981). Monoamine me-
tabolites in cerebrbrospinal fluid in relation to depressive 
illness, suicidal behaviour and personality. In: Angrist, B.; 
Burrows, G.; Lader, M.; Lingjaerde, O.; Sedvall, G.; 
Wheatley, D. (Eds.). Recent Advances in Neurop-
armacology. New York: Pergamon Press, pp 257-
Asberg, M.; Bertllsson, L; Tuck, D.; Cronholm, B.; Sjoq-
vist, F. (1973). Indoleamine metabolites in the 
cerebrospinal fluid of depressedpatients before and during 
treatment with nortryptiline. Clin. Pharmacol Ther., 14, 
277-286. 
Asberg, M.; Nordstrom, P.; Traskman-Bendz, L. (1986a). 
Cerebrospinal fluid studies in suicide: An overview. Ann. 
N. Y. Acad. Sci., 487,243-255. 
Asberg, M.; Nordstrom, P.; Traskman-Bendz, L. (1986b). 
Biological factors in suicide. In: Roy, A. (Ed.). Suicide. 
Williams and Wilkins, Baltimore. 
Asberg, M.; Traskman, L; Thoren, P. (1976). 5-HIAA in 
the cerebrospinal fluid- a biochemical suicide predictor? 
Arch. Gen Psychiat., 33,1193-1197. 
Banki, CM.; Arato, M. Papp, Z.; Kurcz, M. (1984). 
Biochemical markers in suicidal patients: Investigations 
with cerebrospinal fluid amine metabolites and neuroen-
docrine tests. J Affect Disord, 6,341-350. 
Banki, CM.; Molnar, G. (1981). Cerebrospinal fluid 5-
Hydroxyindolcacetic acid as an index of central serotoner-
gic processes. 
Banki, CM.; Molnar, G.; Fekete, I. (1981V Correlation of 
individual symptoms and other clinical variables with 
cerebrospinal fluid amine metabolites and trytophan in 
depression. Arch Psychiat Nervkrankh., 229,343-353. 
Ballengcr, J.C.; Goodwin, P.K.; Major, L.V. tt »L (1979). 
Alcohol and central serotonin metabolism in ami). Quoted 
in Ledberg et al. (1985). 
Berrettini. W.H.; Nurnberger, J.I Jr.; Narrow, W.; Sim-
mons-Ailing, S.; Gershon, £s. (1986). Cerebrospinal fluid 
studies of bipolar patients with and without a history of 
suicide attempts. Ann N Y Acad Sci., 487,197-201. 
Bertllsson, L.; Tuck, JR.; Stwers, B. (1980). Biochemical 
effects of zimelidine in man. Eur J Clin Pharmacol, 18,483-
487. 
Beskow, J. (1979). Suicide and mental disorder in Swedish 
men. Acta Psychiat Scand., suppl 277. 
Bjerkenstedt, L.; Gullberg, B.; Haanryd, C; Sedvall, G. 
(1977). Monoamine metabolite levels in CSF of psychotic 
women treated with melperone or thiothixines. Arch. Gen. 
Psychiat. Nervenkr., 224,107. 
Bowers, M.B. Jr. (1972). Cerebrospinal fluid 5-hydroxyin-
doleacetic acid (5-HIAA) and homovanillic acd (HVA) 
following probenecid in unipolar depressives treated with 
amitryptihne. Psychopharmacologia, 23,26-33. 
Branchey, L.; Branchey, M.; Shaw, S.; Lieber, C. (1984). 
Depression, suicide and aggresion'in alcoholics and their 
relationship to plasmaamino acids. Psychiat Res, 12, 219-
Brown, G.L.; Ebert, M.H.; Goyer, P.F.; Jfmerson, D.C.; 
Klein, W.J.; Bunney, W.E.; Goodwin, F.K. (1982). Aggres-
sion, suicide and serotonin : Relationships to CSF amine 
metabolites. Amer J Psychiat., 139, 741-746. 
Brown, G.L; Goodwin, F.K. (1986). Cerebrospinal fluid 
correlates of suicide attempts and aggresion. Ann N Y 
Acad Sci, 487,243-255. 
Brown, G. 1_; Goodwin, F.K.; Ballenger, F.C.; Goyer, P.F. 
and Major, L.F. (1979). Aggresion in humans correlates 
with cerebrospinal fluid amine metabolites. Psychiat Res, 
12,131-139. 
Buchsbaum, M.S.; Coursey, R.D.; Murphy, D.L. (1976). 
The biochemical high-risk paradigm : Behavioural and 
familial correlates of low platelet monoamine oxidase ac-
tivity. Science, 194,339-341. 
Buchsbaum, M.S.; Haier, R.J.; Murphy, D.L. (1977). 
Suicide attempts, platelet monoamine oxidase and the 
average evoked response. Acta Psychiat Scand, 56,69-79. 
Bulat, M.; Zivkovic, B. (1971). Origins of 5-hydroxyin-
doleacetic acid in the spinal fluid. Science, 173,738-740. 
Bunney, W.E. Jr.; Fawcett, J.A. (1965). Possibility of a 
biochemical test for suicidal potential. Arch Gen 
Psychiatry, 13, 232-239. 
Bunney, W.E. Jr.; Fawcett, J.A.; Davis, J.M. et al. (1969). 
Quoted in Ninan et al. (1984). 
Carlsson. A.; Svennerholm, L.; Wingblad, B. (1980). 
Seasonal and circadianmonoamine variation in human 
brains examined post mortem. Aca Psychiat Scand, Suppl. 
280,75. 
Carrol, BJ.; Greden, J.F.; Feinberg, M. (1981). Suicide, 
neuroendocrine dysfunction and CSF 5-HIAA concentra-
tions in depression. Adv Biosci, 31,307-313. 
Coppen, A.; Prang*, AJ. Jr.; Whybrow, P.C.; Noguera, R 
(1972). Abnormalities of indolamines in affective disor-
ders. Arch Gen Psychiat., 26,474^78. BIOLOGICAL MARKERS OF SUIODAL BEHAVIOUR 195 
Coryell, W.; Schlesser, M.A. (1981). Suicide and the 
dexamethasone supression test in unipolar depression. 
Amer J Psychiat., 138,1120-1121. 
Canon, &; Joseph, MIL; Knott, PJ. (1972). Effect of 
immobilization and food deprivation on rat brain tryp-
tophan metabolism. J Neurochem, 19,1967. 
Canon, G.; Kantamanlne, B.D.; van BoxeL P. (1980). 
Substances related to seotonin in plasma and in lumber and 
ventricular CSF of psychiatric patients. Acta Psychiat 
Scand, 61 (suppl. 280), 3. 
Editorial (1987). Serotonin, suicidal behaviour, and impul-
sivity. Lancet, October 24,949-950. 
Ettlinger, R. (1975). Evaluation of suicide prevention after 
attempted suicide. Acta Psychiat Scand., suppl. 260. 
Feud, S. (1953). Mourning and melancholia. In: Strachey, 
J.; Strachey, A.; Tyson, A. (Eds.). Standard edition of the 
complete psychological works of Sigmund Freud. Hogarthy 
Press, London, pp 237-260. 
Gattaz, W.F4 Waidmeier, P. and Beckmann, H. (1982). 
CSF' monoamine metabolites in schizophrenic patients. 
•Acta Psychiat. Scand., 66,350. 
Gibbons, R.D. and Davis, J.M. (1985). A note on the 
distributed form of the Asbergetal., CSF monoamine data. 
Acta Psychiat. scand., 72,582. 
Gomes, V.C.R.; Shanley, RC; Potgieter, L and Rons, J.T. 
(1980). Noradrenaline overactivity in chronic 
schizophrenia: evidence based on CSF noradrenaline and 
cylic nucpeotide concentration. Brit. J. Psychiat., 137,346. 
Gottfrks, C.G.; Oreland, L,; Wiberg, A.; Wlnblad, B. 
(1975). Lowered monoamine oxidase activity in brains from 
alcoholic suicides. J Neurochem, 25,667-673. 
GoUMes, C.G.; von Knorrlng, L. Oreland, L. (1980). Plat-
let monoamine oxidase activity in mental disorders. 2. Af-
fective psychoses and suicidal behaviour. Prog 
Neuro-Psychopharmacol, 4,185-19^. 
Grole, S.S.; Moses, S.G.; Robins, E.; Hmdgens, R.W4 
Cronlnger, A.B. (1974). A study of selected catecholamine 
metabolizing enzymes: A comparison of depressive 
suicides and alcoholic suicides with controls. J Neurochem, 
23,791-802. 
Hallert, C; Astrom, J.; SedvalL G. (1982). Psychic distur-
bances in adult coeliac diastases. III. Reduced central 
monoamine metabolites and signs of depression. Scand J 
Gastroenterol, 17,25-28. 
HaaMtaa, M (1960). A rating scale for depression. J 
Neuro Neurosurg Psychiat, 23,56-62. 
Johansson, &; Roos, RE. (1967). 5-hydroxyindoIeacetic 
acid and homovanillic acid levels in the cerebrospinal fluid 
of-healthy volunteers and patients-with Parkinson's 
syndrome. Life Sci, 6,1449-1454. 
Johanaon, G.; Roos, B.E. (1975). Concentration of 
monoamine metabolites in human lumber and cisternal 
cerebrospinal fluid. Acta Neuro Scand, 52,137. 
Kaoerl, G.; GUg, T.; Eisentnenger, W.; Spann, W. (1984). 
Quoted in Asberg et al. (1986a). 
Levy, B.; Hansen, E. (1969). Failure of the urinary test for 
suicide potential. Arch Gen Psychiat, 20,415-418. 
Lidberg, L.; Tuck, J.R^ Asberg, M4 Scalia-Tomba, G.P.j 
Bertikson, L. (1985). Homicide, suicide, and CSF5-HIAA. 
Acta Psychiat Scand, 71,230-236. 
LlnkowsU, P.; van Wettere, J.P.; Kerkhob, M^ Gregorie, 
F^ Brauman, H^ Mendlewkx, J. (1984). Violent suicidal 
behaviour and the thyrotropin-releasing hormone-thyroid-
stimulating hormone test : A clinical outcome study; 
Neuropsychobiol, 12,19-22. 
Linnoila, M.; Virkkunen, M.; Scheinln, M. Nuutila, A.; 
Rlmon, R.; Goodwin, F.K. (1983). Low cerebrospinal fluid 
5- hydroxyindoleacetic acid concentration differentiates 
impulsive from nonimpulsivc violent behaviour. Life Sci, 
33,2609- 2614. 
Lloyd, K.G.; Farley, I J.; Deck, J.H.N.; Homy Klewka, O. 
(1974). Serotonin and 5-hydrpxyindoleacetic acid in dis-
crete areas of the brainstem of suicide victims and control 
patients. Adv Biochem Psychopharmacol, 11,387-397. 
Lopez-Ibor, J J.; Saiz-Ruiz, J.; Perez, de los Cobos, J.C 
(1985). Biological correlations of suicide and aggressivity 
in major depressions (with melancholia) : 5- hydroxyin-
doleacetic acid and Cortisol in cerebral spinal fluid, 
dexamethasone suppression test and therapeutic response 
to 5-hydroxytryptopnan. Neuropsychobiol, 14,67-74. 
' Losonczy, M.F.; Mobs, R.C.; Davis, K.L. (1984). Seasonal 
variations of KCman lumbar CSF neurotransmitter meta-
bolite concentrations. Psychiatry Res, 12,79-87. 
Mann, J J.; Arango, V.; Marzuk, P.M.; Theccanat, S.; Reb, 
DJ. (1989). Evidence for the 5-HT hypothesis of suicide : 
A review of post-mortem studies. Brit J Psychiat., 155 
(suppl. 8), 7-14. 
Mann, JJ.; Stanley, M. (1984). Postmortem monoamine 
oxidase enzyme kinetics in the frontal cortex of suicide 
victims and controls. Acta Psychiat Scand, 69,135-139. 
Menninger, K. (1933). Psychoaanlytic aspects of suicide. 
Int J Psychoanal, 14,376-390. 
Meltzer, H.Y. (1988). Role of serotonin in depression. 
Psychopharmacol, % (suppl.), 134. 
Mignot, E.; Serrano, A.; Laude, D.; Elghozi, J.L.; Dedek, 
J.; Scatton, B. (1985). Measurement of 5-HIAA levels in 
ventricular CSF (by LCEC) and in striatum (by in vivo 
voltammetry) during pharmacological modifications of 
serotonin metabolism in the rat. J Neural Transm, 62, 
117-124. 
Montgomery, S.A.; Montgomery, D. (1982). Phar-
macological prevention of suicidal behaviour. J Affect Dis-
orders, 4,291- 298. 
Morand, C; Young, J.N.; Ervtn, F.R. (1983). Qinical 
response of aggressive schizophrenics to oral tryptophan. 
Biological Psychiatry, 18,575-578. 1%  J.K.TRIVEDI 
Musceltola, G.; Goodwin, F.K.; Poller, W.Z.; Claeyf. 
M.M.; Markey, S.P. (1978). Imipramine and desipraminc 
in plasma and spinal fluid. Arch Gen Psychiat, 35,621-625. 
Nkoletli, F.; RaiTaile, R.; Falsaperla, A.; Pati, R. (1981). 
Orcadian variation in 5-hydroxyindoleacetic acid and levels 
of human cerebrospinal fluid. Eur Neurol, 20,834-838. 
Nlnan, P.T.; van Kammen, D.P.; Llnnoila, M. (1985). 
I-etter to the editor. Amer J Psychiat, 142,148. 
Nlnan, P.T.; van Kammen, D.P.; Scheinin, M.; Llnnoila, 
M.; Bunney,:W.E. Jr.; Goodwin, F.K. (1984). CSF 5-
hydroxyindolejacetic acid in suicidal schizophrenic patients. 
Amer J Psychiat, 141,566-569. 
Nordin, C; Siwerc, B.; Bertilsson, I- (1982). Site of lumbar 
puncture influences levels of monoamine metabolites. Let-
ter to the editor. Arch Gen Psychiat, 39,1445. 
Oveall, J.E. and Gorham, D.R. (1962). The brief 
psychiatric rating scale. Psychological Reports, 10,799-812. 
Oreland, L.; Wldberg, A.; Asberg, M.; Traskman, L.; 
SJostrand, I.; Thoren, P.; Bertilsson, L.; Tybring, G. 
(1981). Platlet MAO activity and monoamine metabolites 
in cerebrospinal fluid in depressed and suicidal patients 
and in healthy controls. Psychiatry Research, 4,21-29. 
Owen, F.; Cross, AJ.; Crow, TJ.; Deakin, J.F.W.; Ferrier, 
I.N.; Loflhouse, R.; Poulter, M. (1983). Brain 5-HT2 recep-
tors and suicide. Lancet, ii, 1256. 
Paykel, E.S.; Rassaby, E. (1978). Classification of suicide 
attempts by cluster analysis. Brit J Psychiat, 133,45-52. 
Post, R.M.; Ballenger, J.C.; Goodwin, F.K. (1980). 
Cerebrospinal fluid studies of neurotransmitter function in 
manic and depressive illness. In : Wood, J.H. (Ed.). 
Neurobiology of cerebrospinal fluid. I. New York, Plenum 
Press, pp 685-717. 
Post, R.MJ; Goodwin, F.K. (1974). Effects of amitryptiline 
and imipramine on amine metabolites in the cerebrospinal 
fluid of depressed patients. Arch Gen Psychiat, 30,234-239. 
Post, R.M.; Kotln, J.; Goodwin, F.K.; Gordon, E. (1973). 
Psychomotor activity and cerebrospinal fluid amine meta-
bolites in affective illness. Amer J Psychiat, 130.67-72. 
Post, R.M.; Goodwin, F.K.; Gordon, E. el al. 
(1973).Quoted in Ninan et al. (1984). 
Roy, A.; Lamparskl, D.; De Jong, J.; Adinoff, B.; Ravitz, 
B.; George, D.T.; Null, D.; Llnnoila, M. (1990). 
Cerebrospinal fluid monoamine metabolites in alcoholic 
patients who attempt suicide. Acta Psychiat Scand, 81, 
Roy, A.; Agren, li.; Llnnoila, M.; Doran, A.R.; Cutler, L.R. 
and Paul. S. (1986). Reduced CSF concentrations of 
homovanillic acid to 5-HIAA ratios in depressed patients: 
Relationship to suicidal behaviour and OST. Amer. J. 
Psychiat.. 143, 1539-1545. 
Roy-Byrne, P.; Post, R.M.; Rublnow, D.R.; Llnnoila,' M^ 
Savard, R.; Davie, D. (1983). CSF 5-HIAA and personal 
and family history of suicide in affectively i<l patients : a 
negative study. Psychiatry Res, 10, 263-274. 
Reus, V.I. (1982). Pituitary-adrenal disinhibition as the 
independent variable in the assessment of behavioural 
symptoms. Biol Psychiat, 17,316-317. 
Rydin, E.; Schalling, D.; Asberg, M. (1982). Rorschach 
ratings in depressed and suicidal patients with low levels of 
5- hvdroxyindoleacetic acid in cerebrospinal fluid. 
Psychiatry Res, 7,229-243. 
Schalling, D.; Asberg, M.; Edman, G.; Levander, S. (1984). 
Impulsivity, nonconformity and sensation seeking as re-
lated to biological markers for vulnerability. Clin 
Neuropharmacol, 7,746-747. 
Sedvall, G.; Fyro, B^ GuIIberg, B. et aL (1980b). Quoted in 
Brown et al. (1982). 
Sedvall, G.; Fyro, B.; GuIIberg, B.; Nyback, H.; WieseL 
F.A.; Wode-Helgodt, B. (1980). Relationship in healthy 
volunteers between concentrations of monoamine metabo-
lites in cerebrospinal fluid and family history of psychiatric 
morbidity. Brit J Psychiat, 136,366-374. 
Sedvall, G.; Nyback, II.; Oxenslierna, G. et aL (1980a). 
Quoted in Brown et al. (1982). 
Sedvall, G.; Oxentierng, G. (1986). Quoted in Asberg et al. 
(1986b). 
Sidney Jones J-; Stanley, B.; Mann, J.J.; Frances, AJ.; 
Guido, JR.; Traskman-Bendz, L.; WlncheL R.; Brown, 
R.P.; Stanley, M. (1990). CSF 5-HIAA and HVA con-
centration in elderly patients who attempted suicide. Amer 
J Psychiat, 147,1225-1227. 
Sjoquist, B.; Johansson, B. (1978). A comparison between 
fluorometric and mass fragmentographic determinations 
of homovanillic acid and 5-hydroxyindoleacetic acid in 
human cerebrospinal fluid. J Neurochem, 31,621-625. 
Soubrie, P. (1986). Reconciling the role of central 
serotonin neurones in human and animal behaviour. Behav 
Brain Sci, 9,319-364. 
Stanley, M.; Mann, J J. (1983). Incresed scrotonin-2 bind-
ing sites in frontal cortex of suicide victims. Lancet, i, 214-
216. 
Stanley, M.; Traskman-Bendz, L.; Dorovini-Zis, K. 
(1985). Correlations between aminergic metabolites simul-
taneously obtained from human CSF and brain. Life Sci, 
37,1279-1286. 
Stanley, M.; Virgllio, J.; Gershon, S. (1982). Tritiated im-
ipramine binding sites are decreased in the frontal cortex 
of suicides. Science, 216,1337-1339. 
Targum, S.D.; Rosen, L.; Capodanno, A.E. (1983). The 
dexamethasone suppression test in suicidal patients with 
unipolar depression. Amer J Psychiat, 140,877-879. 
Traskman, L.; Tybring, G.; Asberg, M.; Bertilsson, U; 
Lantto, O.; Schalling, D. (1980). Cortisol in the CSF of 
depressed and suicidal patients. Arch Gen Psychiat, 37, 
761-767. 
Traskman, L.; Asberg, M.; Bertilsson, L.; SJostrand, L. 
(1981). Monoamine metabolites in CSF and suicidal be-
haviour. Arch Gen Psychiat, 38,631-636. BIOLOGICAL MARKERS 
Traskman, L.; Asberg, M.; BertlLsson, L.; Cronholm, B.; 
Mellslrom, B.; Neckers, L.M.; Sjoquist, F.; Thoren, P.; 
Tybring, G. (1979). Plasma levels of chlorimipramine and 
its desmethyl metabolite during treatment of depression. 
Differential biochemical and clinical effects of the tut) 
compounds. Clin Pharmacol Ther, 26,600-610. 
Traskman-Bendz, U; Asberg, M.; Bertllsson, L.; Thoren, 
P.. (1984). CSF monoamine metabolites of depressed 
patients during illness and after recovery. Acta Psychiat 
Scand, 69,333-342. 
Valzelli, L. (1981). Psychobiology of aggresion and 
violence. Raven Press, New York. 
van Pragg, H.M. (1977). Significance of biochemical 
parameters in the diagnosis treatment and prevention of 
depressive disorders. Biol. Psychiat, 12,101-131. 
van Pragg, H.M. (1982a). Depression, suicide, and the 
metabolism of serotonin in the brain. J Affect Disord, 4, 
275-290. 
van Praag, H.M. (1982b). Neurotransmitters and CNS 
disease depression. Lancet, ii, 1259-1264. 
van Praag, H.M. (1983). CSF5-HIAA and suicide in non-
depressed schizophrenics. Lancet, i, 977-978. 
van Praag, H.M. (1991). Editorial: Serotonergic dysfunc-
tion and aggression control. Psychol Med, 21,15-19. 
SUICIDAL BEHAVIOUR 197 
van Praag, H.M.; Asnis, G.M.; Khan, R.S.; Brown, S.U; 
Korn, M.; Harkavy Friedman, J.M.; Welder, S. (1990). 
Monoamines and abnormal behaviour: A multi-aminergic 
perspective. Brit J Psychiat, 157,723-734. 
van Praag, H.M.; de Haan, S. (1977). Central serotonin 
metabolism and the frequency of depression. Psychiatry 
Res, 1,219-224. 
van Praag, H.M.; Pulchik, R (1984). Depression-type and 
depression-severity in relation to risk of violent suicide 
attempt. Psychiatric Res, 12,333-338. 
van Praag, H.M.; Pulchik, R. (1985). An imeprical study 
on the "cathartic effect" of attempted suicide. Psychiat Res, 
16,123-130. 
van Praag, H.M.; Pulchik, R.; Come, H. (1986). The 
^ serotonin hypothesis of«(auto) aggression : Critical ap-
praisal of the evidence. Ann N V Acad Sci, 487,150-167! 
Volavka, J.; Crowner, M.; Brizer, D.; Convil, A.; van 
Praag, H.M.; Cooper, T. (1990). Tryptophan treatment of 
aggressive psychiatric patients. Quoted in van Praag (1991). 
Weir, R.L.; Chase, T.N.; Ng Lit Y. el aL (1973). Quoted in 
Ninan et al. (1984). 
Weisman, A.D.; Worden, J.W. (1972). Risk/rescue rating 
in suicide assesment. Arch Gen Psychiat, 26,553-560. 
Wode-Helgodt, B.; Sedvall, G. (1978). Correlations be-
tween heght of subject and concentration of monoamine 
metabolites in cerebrospinal fluid from psychotic men and 
women. Commun Psychopharmacol, 2,177-183. 